Commentary on “Hormone therapy and increased risk of psoriasis in women” - 17/10/25
Doi : 10.1016/j.jaad.2025.07.016
Ching-Ting Ting a, ⁎ 
, Brian Shiian Chen, BSc a, b, James Cheng-Chung Wei, MD, PhD c, d, e, ⁎
, Brian Shiian Chen, BSc a, b, James Cheng-Chung Wei, MD, PhD c, d, e, ⁎ a School of Medicine, Chung Shan Medical University, Taichung, Taiwan
b Department of Medical Education, Chung Shan Medical University Hospital, Taichung, Taiwan
c Institute of Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
d Division of Allergy, Immunology, and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan
e Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan
∗Correspondence to: Ching-Ting Ting, School of Medicine, Chung Shan Medical University, No.110, Sec 1, Jianguo N. Rd, Taichung City 40201, TaiwanSchool of MedicineChung Shan Medical UniversityNo.110, Sec 1, Jianguo N. RdTaichung City40201Taiwan∗∗James Cheng-Chung Wei, MD, PhD, Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan Institute of Medicine/Department of Nursing, Chung Shan Medical University, Taichung, Taiwan, No.110, Sec 1, Jianguo N. Rd., South District, Taichung City 40201, TaiwanDepartment of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan Institute of Medicine/Department of Nursing, Chung Shan Medical University, Taichung, TaiwanNo.110Sec 1Jianguo N. Rd.South DistrictTaichung City40201Taiwan
Key words : clinical cases, database studies, evidence-based medicine, psoriasis, hormone therapy
Le texte complet de cet article est disponible en PDF.
| Funding sources: None. |
|
| Patient consent: Not applicable. |
|
| IRB approval status: Not applicable. |
|
| Data availability statement: The data underlying this article will be shared on reasonable request to the corresponding author. |
© 2025
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 93 - N° 5
P. e197 - novembre 2025 Retour au numéro
Article précédent
- Pearl sign: Enhanced visualization of molluscum contagiosum Henderson-Patterson bodies under UV dermatoscopy
- Ece Gokyayla
- Understanding JAK inhibitor toxicity
- Athira Sivadas, Kevin W. Byram, Manuel Valdebran, Tyler Beck
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?